Where does DNA Script rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), DNA Script ranks #18,542 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does DNA Script hold?

DNA Script holds 15 US utility patents granted between 2020 and 2025, spanning 10 technology areas.

What is DNA Script's Innovation Score?

DNA Script has an Innovation Score of 40.5 out of 100 (top 35% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is DNA Script's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for DNA Script.

What does claim depth mean for DNA Script's patents?

DNA Script's patents average 13.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the DNA Script patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

DNA Script

Q: What technology areas does DNA Script focus on?

DNA Script's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 11 patents, ranking #932 of 4,144 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 15 granted patents across 10 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, DNA ranks #18,542 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 10 technology areas.

#18,542
of 49,997 US assignees by volume: Top 35%
by Innovation Score (40.5/100): 13.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R18542 · Foreign Corporation #18,542 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 15 grants
MID-PACK #18,542/49,997
PHOTO-FINISH DIC (TOKYO)
CPC-FOCUS C12N · 10 areas
INNOV-PAR 40.5/100
CLAIMS-RICH 13.5 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: DIC Corporation (TOKYO) (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How DNA’s 40.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (24%) Velocity 11.7 pts (29%) Breadth 11.2 pts (28%) Claim depth 8.1 pts (20%)

Qualcomm Incorporated · highest

85
DNA Script · this assignee

41
3D Lighting… · lowest

7

What this shows DNA's Innovation Score is 40.5/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for DNA?

Each dot is one of DNA’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). DNA’s own 13.5 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

DNA vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where DNA's grants concentrate

DNA Script is a focused PatentsView assignee: 10 CPC subclasses with 73.3% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2022. By volume, DNA sits between DIC Corporation (TOKYO) and Dri-steem Corporation.

DNA's three-year grant acceleration

DNA Script shows 7 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

DIC (Tokyo)

15
Dipharma Francis…

15
Dish Network

15
DL Chemical

15
Dongguan Yulong T…

15
Doselogix

15
Dpix

15
Dri-steem

15
DNA Script ◀

15

What this shows DNA holds 15 patents at rank #18,533, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near DNA

By rank, the assignees closest to #18,533 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in DNA's primary technology class.

DNA's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

DNA Script patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	13.3%
2021	2	13.3%
2022	1	6.7%
2023	1	6.7%
2024	5	33.3%
2025partial year	4	26.7%

Which technologies does DNA Script patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 11

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 7

C12Y - Enzymes 6

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 5

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

G11C - Static Stores 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

DNA Script's patent record in context - here's where to go next.

DNA Script's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 73.3% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #18,542 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare DNA Script against DIC Corporation (TOKYO), an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.